Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Introduction to Hemostasis01:05

Introduction to Hemostasis

6.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.0K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

5.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
Disorders of Hemostasis01:24

Disorders of Hemostasis

726
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
726
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

4.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.8K
Coagulation01:09

Coagulation

5.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Coupled Electronic and Ionic Conductivity in Strain-Stiffening Hydrogels.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Strain stiffening and compression-induced softening of composite fibrous hydrogels derived from rod-shaped nanoparticles and a synthetic copolymer.

Materials horizons·2026
Same author

Advanced polyelectrolyte complexes for ultrafast hemostasis and blood superabsorption.

Acta biomaterialia·2025
Same author

Controlling Enzymatic Degradation of Carboxyl-Modified Chitosan and Hyaluronic Acid Biopolymers Using Dynamic Covalent Cross-Linking.

ACS applied bio materials·2025
Same author

Nanocolloidal hydrogel mimics the structure and nonlinear mechanical properties of biological fibrous networks.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same author

Colloidal Clusters and Networks Formed by Oppositely Charged Nanoparticles with Varying Stiffnesses.

ACS nano·2023

相关实验视频

Updated: Jun 9, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

793

外部出血和先进的生物巨分子用于血液静止.

Sajjad Fanaee1, William Austin1, Mark Filiaggi1,2

  • 1School of Biomedical Engineering, Dalhousie University, Halifax, NS B3H 4R2, Canada.

Biomacromolecules
|October 28, 2024
PubMed
概括

本综述探讨了先进的静血材料,旨在改善血栓形成和控制出血. 这些创新的生物材料有可能在临床和紧急情况下获得更好的结果.

更多相关视频

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

235
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

相关实验视频

Last Updated: Jun 9, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

793
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

235
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

科学领域:

  • 生物材料科学 生物材料科学
  • 血液静止研究 血液静止研究
  • 医疗器械开发 医疗器械开发

背景情况:

  • 出血是一个重大的临床挑战,促使广泛的血液静止研究.
  • 人体采用复杂的机制来形成血块和血液静止.
  • 生物材料正在开发中,以增强身体的自然出血控制反应.

研究的目的:

  • 审查血液静止和出血的机制.
  • 检查用于研究静血材料的体外和体内模型.
  • 提供当前和新兴的静血技术的全面概述.

主要方法:

  • 关于静血机制的文献综述.
  • 对出血模型和技术的分析.
  • 基于功能 (吸收剂,粘合剂,促凝剂) 的静血材料的分类.

主要成果:

  • 详细检查各种静血材料,包括吸收剂,湿粘剂和促凝剂类型.
  • 材料在市场,临床前试验和研究阶段的概述.
  • 识别血液静止技术的进步.

结论:

  • 新兴的静血材料显示出改善出血控制的显著前景.
  • 这些进展有可能提高临床和急诊环境中的患者护理.
  • 对静血生物材料的持续研究对于解决出血并发症至关重要.